Amsurg Corp. (AMSG) Trading Down 3.1%
Amsurg Corp. (NASDAQ:AMSG) shares were down 3.1% during trading on Tuesday . The stock traded as low as $62.88 and last traded at $63.01, with a volume of 746,022 shares traded. The stock had previously closed at $65.04.
Several research analysts have commented on AMSG shares. Jefferies Group restated a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Robert W. Baird restated a “buy” rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Zacks Investment Research upgraded shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a report on Monday, July 11th. Goldman Sachs Group Inc. restated a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Finally, Citigroup Inc. lowered shares of Amsurg Corp. from a “buy” rating to a “neutral” rating in a report on Thursday, June 16th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Amsurg Corp. currently has an average rating of “Buy” and a consensus target price of $93.90.
The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of 18.65 and a beta of 0.65. The firm’s 50 day moving average price is $66.59 and its 200-day moving average price is $73.95.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/amsurg-corp-amsg-trading-down-3-1.html
Amsurg Corp. (NASDAQ:AMSG) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. The company earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. Amsurg Corp.’s quarterly revenue was up 21.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.97 earnings per share. Equities research analysts predict that Amsurg Corp. will post $4.33 earnings per share for the current year.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction on Friday, August 26th. The shares were sold at an average price of $63.65, for a total transaction of $477,375.00. Following the completion of the transaction, the insider now directly owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.30% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Emerald Acquisition Ltd. purchased a new position in Amsurg Corp. during the second quarter valued at approximately $106,000. Smith Asset Management Group LP raised its stake in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock worth $133,000 after buying an additional 1,700 shares in the last quarter. Invictus RG raised its stake in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock worth $142,000 after buying an additional 1,698 shares in the last quarter. Checchi Capital Advisers LLC bought a new stake in shares of Amsurg Corp. during the second quarter worth about $157,000. Finally, Advisor Group Inc. bought a new stake in shares of Amsurg Corp. during the second quarter worth about $202,000. 99.12% of the stock is owned by institutional investors.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.